prof. dr. Frank Peelman
- Work address
-
Technologiepark-Zwijnaarde 75, FSVMII
9052 Zwijnaarde - Frank.Peelman@UGent.be
Show
Sort by
-
- Journal Article
- A1
- open access
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication
-
- Journal Article
- A1
- open access
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models
-
- Journal Article
- A1
- open access
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant
-
Selected IL-1 activity on CD8+ T cells allows for safe enhancement of cellular immune responses
-
- Journal Article
- A1
- open access
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies
-
- Journal Article
- A1
- open access
Functional characterization of the first missense variant in CEP78, a founder allele associated with cone‐rod dystrophy, hearing loss and reduced male fertility
-
Expansion of the role and functional characterization of a missense variant in CEP78 associated with cone-rod dystrophy and hearing loss
(2019) -
Expansion of the role and functional characterization of a missense variant in CEP78 associated with cone-rod dystrophy and hearing loss
-
Towards the use of interleukin-1β as vaccine adjuvant
-
- Journal Article
- A1
- open access
The N‐terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond